Navigation Links
8 M € from EU to enhance access by scientists to the largest European 'biobanks'
Date:4/10/2013

In response to a specific infrastructure call of the Seventh Framework Programme (FP7) of the European Commission, BBMRI-LPC*, a European-wide project involving 30 partners from 17 countries, has received a 8M funding to enhance access by academic and industry scientists to the largest European 'biobanks'.

The project represents the next phase of the successful EU biobanking programme BBMRI (Biobanking and Biomolecular Resources Research Infrastructure), which was operational from 2007-2011.

BBMRI-LPC led by the University Medical Centers of Helsinki (Finland) and Leiden (the Netherlands) had its kick-off meeting in Amsterdam 11-12 February and will now run for the following 4 years. The project will specifically focus on large population cohorts and aims to enable academic and industrial scientists to improve our understanding of human biology, thereby leading to novel and better medicines and treatments for common and rare diseases.

Over recent years, biomedical research has crossed international borders in large, collaborative studies substantiating the value of collaboration between experts from different fields as well as the value of large numbers of samples. In the past decades, European countries have invested millions euros of funding and substantial amount of time for the establishment of large collections of volunteering individuals' biological samples and health-related information to be used in the research of human health and disease. The access to this study material, however, is often hindered by the limited resources for sharing samples and data between the fellow scientists, and by differences between nearby countries in their legal and ethical procedures.

The BBMRI-LPC project endeavors to unite the large study sets of the European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) and the International Agency for Research on Cancer (IARC), thereby achieving a biobanking network with a scale of integration that is unique worldwide. BBMRI-LPC will assist the European health industry by promoting new and existing public-private partnerships, which will strengthen the European niche in the development of medicine and treatments as well as assist governments in returning the investment made by all European tax payers.


'/>"/>

Contact: Markus Perola
markus.perola@helsinki.fi
358-206-108-727
University of Helsinki
Source:Eurekalert

Related biology news :

1. New grants to innovation corps nodes further enhance public-private partnership
2. New therapy for heart failure may enhance bodys stem cell response at cardiovascular injury site
3. Hydrogen peroxide vapor enhances hospital disinfection of superbugs
4. Discovery may pave way to genetically enhanced biofuel crops
5. Surface analysis techniques for advanced materials enhance Mazovias research potential
6. MedNet Solutions Announces Latest Enhancements To Its iMedNet EDC eClinical Solution
7. Partnership enhances biology teaching at California community colleges
8. Potential drug molecule shows enhanced anti-HIV activity
9. Ken Bierly of the Oregon Watershed Enhancement Board to receive ESA Regional Policy Award
10. Enhanced royal jelly produces jumbo queen bee larvae
11. Study identifies pathway to enhance usefulness of EGFR inhibitors in lung cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2016)... , May 12, 2016 WearablesResearch.com ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... -- First quarter 2016:   , Revenues ... first quarter of 2015 The gross margin was 49% ... and the operating margin was 40% (-13) Earnings per ... from operations was SEK 249.9 M (21.2) , Outlook ... 7,000-8,500 M. The operating margin for 2016 is estimated ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or ... its major shareholders, Clean Technology Fund I, LP and ... based venture capital funds which together hold ... a fully diluted, as converted basis), that they have ... entire equity holdings in Biorem to TUS Holdings Co. ...
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
Breaking Biology Technology: